Epidermolysis Bullosa

Epidermolysis bullosa (EB) is a rare and potentially debilitating genetic disorder that affects the skin and mucous membranes. Characterized by extreme skin fragility, EB can lead to the formation of painful blisters and sores as a result of minor friction or trauma. It is caused by mutations in the genes responsible for producing proteins that help keep the layers of the skin attached to each other. The most severe forms of the disease can lead to widespread blistering, open wounds, scarring and internal complications. It can significantly impact quality of life, causing chronic pain, mobility challenges and increased vulnerability to infections. Treatment of epidermolysis bullosa focuses on managing symptoms, preventing infection and promoting wound healing. It may involve daily wound care, pain management, bandaging and addressing nutritional needs. Innovative therapies and potential genetic interventions are currently being investigated. Raising awareness and advancing research are essential to enhancing treatment options and ultimately finding a cure for this challenging condition.